-
Website
http://venturebeat.com/ -
Original page
http://venturebeat.com/2007/05/31/jazz-pharma-takes-it-on-the-chin-raises-less-than-expected-108m-in-ipo/ -
Subscribe
All Comments -
Community
-
-
Top Commenters
-
Popular Threads
VentureBeat: Jazz Pharma takes it on the chin, raises less-than-expected $108M in IPO
-
Cyndi Feigenbaum · 1 year agoXyrem is a drug with a great future and many uses. It was misused by children so lets get it straight. It is a neurotransmiter and if our body stopped producing it we would all be dead.
